SCHEMBL26106590

SCHEMBL26106590

CSCOc1nc(SCc2c(Cl)cncc2Cl)nc2c1CCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 7/20 0.39
▸ GAA P10253 4/20 0.39
▸ LMNA P02545 4/20 0.39
▸ HTT P42858 4/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KMT2A Q03164 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ PLA2G1B P04054 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ ATG4B Q9Y4P1 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26109798 0.87 L3MBTL1 (0.39) L3MBTL1GAALMNAHTTNPC1
SCHEMBL30606643 0.87 L3MBTL1 (0.39) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26108416 0.83 L3MBTL1 (0.40) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26108183 0.80 L3MBTL1 (0.40) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26108779 0.80 L3MBTL1 (0.38) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26107854 0.79 L3MBTL1 (0.38) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26109086 0.79 L3MBTL1 (0.38) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26110179 0.79 GAA (0.43) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26519673 0.78 KMT2A (0.42) L3MBTL1GAALMNAHTTNPC1
SCHEMBL26109601 0.78 KMT2A (0.42) L3MBTL1GAALMNAHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196614-A1 METHODS AND COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS AXONIS THERAPEUTICS, INC. (US) 2023-10-12 — — WO disclosed
Send feedback